Suchergebnisse - "Peng, Haiyong"

PubPharm (5)

1

ROR1-targeting switchable CAR-T cells for cancer therapy

enthalten in: Oncogene | 2022

von Peng, H. | Nerreter, T. | Mestermann, K. | +4

ErratumIn: Oncogene. 2024 Feb 21;:. - PMID 38383728

2

Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications

enthalten in: The Journal of biological chemistry | 2020

von Goydel, R. | Weber, J. | Peng, H. | +5

3

Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2019

von Rydzek, J. | Nerreter, T. | Peng, H. | +6

4

Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2018

von Qi, J. | Li, X. | Peng, H. | +5

5

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

enthalten in: Journal of molecular biology | 2017

von Peng, H. | Nerreter, T. | Chang, J. | +11

1
[1]